Target intelligence / Profile preview

Microbial cell wall and membrane

Molecular classification
Other
01

Overview

The **microbial cell wall and membrane** (collectively, the cell envelope) refer to the essential structures that encase prokaryotic cells, providing shape, structural integrity, protection from osmotic lysis, and selectively controlling entry and exit of substances[1][3][4]. The bacterial cell wall is primarily composed of peptidoglycan, a complex polymer unique to most bacteria, which is cross-linked to confer rigidity[1]. Gram-positive and Gram-negative bacteria differ in cell wall architecture, affecting their staining properties and drug susceptibility. The underlying cytoplasmic membrane is a lipid bilayer rich in proteins, mediating active transport, energy generation (respiration), biosynthesis of essential components, and serving as a platform for cell division[2][3][4][5]. Antibiotics targeting these structures either inhibit synthesis or disrupt integrity, making them critical for antimicrobial therapy. However, "Microbial cell wall and membrane" is not, strictly speaking, a single molecular target but refers to a class of structures; different drugs interact with distinct molecular components within these systems. Thus, the entry is overly broad for a discrete molecular target and is considered incorrect as a canonical, specific drug target[1][3][4][5].

Other names
bacterial cell wallbacterial membraneprokaryotic cell envelopemicrobial envelopecell envelope
02

Mechanism of action

Inhibition of peptidoglycan synthesis (beta-lactams, glycopeptides); Disruption of membrane integrity (polymyxins, daptomycin); Inhibition of cell wall precursor transport (bacitracin); Inhibition of cell wall biosynthetic enzymes (fosfomycin)

03

Biological functions

Structural supportMaintaining cell shapeOsmotic protectionSelective permeabilityCell divisionEnergy transductionBiosynthesis of macromolecules
04

Disease associations

Infection
05

Safety considerations

Rapid development of resistance (especially for membrane-active drugs)Host toxicity (notable for polymyxins)Disruption of beneficial microbiota
06

Interacting drugs

Beta-lactam antibiotics (e.g., penicillins, cephalosporins)

6 more in the full profile.

07

Biomarkers

PeptidoglycanLipoteichoic acidLipopolysaccharide (LPS, in Gram-negative bacteria)Capsule polysaccharides (sometimes)

Beyond the preview

Go deeper on Microbial cell wall and membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell wall and membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call